DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,598,584 | +7.9% | 42,719 | +4.4% | 1.70% | +15.4% |
Q2 2023 | $9,821,040 | +5.0% | 40,921 | +10.2% | 1.47% | -4.1% |
Q1 2023 | $9,356,733 | +18.0% | 37,124 | +24.3% | 1.53% | +16.0% |
Q4 2022 | $7,928,361 | +7.2% | 29,871 | +4.3% | 1.32% | +0.2% |
Q3 2022 | $7,398,000 | +4.9% | 28,641 | +3.0% | 1.32% | +18.2% |
Q2 2022 | $7,052,000 | +18.0% | 27,816 | +36.5% | 1.12% | +39.0% |
Q1 2022 | $5,978,000 | -11.2% | 20,381 | -0.4% | 0.80% | -7.0% |
Q4 2021 | $6,732,000 | +6.1% | 20,461 | -1.8% | 0.86% | -1.5% |
Q3 2021 | $6,342,000 | +12.0% | 20,831 | -1.3% | 0.88% | +8.1% |
Q2 2021 | $5,661,000 | +19.2% | 21,096 | 0.0% | 0.81% | -12.3% |
Q1 2021 | $4,748,000 | -1.1% | 21,096 | -2.4% | 0.92% | -6.0% |
Q4 2020 | $4,803,000 | -0.3% | 21,621 | -3.3% | 0.98% | -9.6% |
Q3 2020 | $4,816,000 | +16.5% | 22,366 | -4.3% | 1.09% | +3.0% |
Q2 2020 | $4,133,000 | +27.8% | 23,371 | 0.0% | 1.06% | +9.4% |
Q1 2020 | $3,235,000 | -10.6% | 23,371 | -0.8% | 0.96% | +18.0% |
Q4 2019 | $3,618,000 | +6.1% | 23,570 | -0.2% | 0.82% | -2.3% |
Q3 2019 | $3,411,000 | -0.1% | 23,620 | -1.1% | 0.84% | -1.9% |
Q2 2019 | $3,414,000 | +9.6% | 23,890 | +1.3% | 0.85% | +6.0% |
Q1 2019 | $3,114,000 | +7.5% | 23,590 | -16.0% | 0.80% | -1.6% |
Q4 2018 | $2,898,000 | -7.2% | 28,100 | -2.3% | 0.82% | +8.5% |
Q3 2018 | $3,124,000 | +7.9% | 28,750 | -2.0% | 0.75% | +4.1% |
Q2 2018 | $2,894,000 | -4.9% | 29,325 | -5.7% | 0.72% | -5.2% |
Q1 2018 | $3,044,000 | -2.3% | 31,085 | -7.4% | 0.76% | -0.4% |
Q4 2017 | $3,117,000 | +7.4% | 33,580 | -0.8% | 0.77% | +0.8% |
Q3 2017 | $2,903,000 | -7.5% | 33,840 | -9.0% | 0.76% | -8.0% |
Q2 2017 | $3,139,000 | -7.4% | 37,195 | -6.1% | 0.83% | -9.7% |
Q1 2017 | $3,389,000 | -44.9% | 39,620 | -49.9% | 0.92% | -47.0% |
Q4 2016 | $6,156,000 | -1.4% | 79,090 | -0.7% | 1.72% | -4.2% |
Q3 2016 | $6,244,000 | -12.9% | 79,656 | +12.2% | 1.80% | -15.2% |
Q2 2016 | $7,171,000 | +4.6% | 71,001 | -1.7% | 2.12% | +1.9% |
Q1 2016 | $6,855,000 | +3.6% | 72,261 | +1.4% | 2.08% | +6.3% |
Q4 2015 | $6,616,000 | +5.7% | 71,235 | -3.0% | 1.96% | +4.8% |
Q3 2015 | $6,257,000 | +0.6% | 73,435 | +1.0% | 1.87% | +8.7% |
Q2 2015 | $6,222,000 | +0.6% | 72,700 | -0.2% | 1.72% | +3.9% |
Q1 2015 | $6,183,000 | +1.3% | 72,830 | +2.3% | 1.66% | +1.4% |
Q4 2014 | $6,101,000 | +15.1% | 71,180 | +2.0% | 1.63% | +12.5% |
Q3 2014 | $5,301,000 | +198.6% | 69,768 | +209.5% | 1.45% | +207.6% |
Q2 2014 | $1,775,000 | +284.2% | 22,541 | +265.6% | 0.47% | +268.8% |
Q1 2014 | $462,000 | – | 6,165 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |